BioSpace News Archive

The FDA has a broad range of activities in the drug and medical device space. Here’s a look at the agency’s work this week.

With 33 approvals from the FDA, Merck’s checkpoint inhibitor Keytruda has become a powerhouse oncology drug and is likely to continue to rack up more regulatory wins.

Nicox SA, an international ophthalmology company, provided business and financial results for Nicox SA and its subsidiaries for the first half of 2022.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for Beyfortus® for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants during their first RSV season.

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, won the Grand Prize Trophy at the 2022 Future Unicorns Awards, whose ceremony took place on September 15, 2022, at the Bourrienne Hotel.

AlzeCure Pharma announced that the company has received new data from the clinical phase I study with repeated dosing of the drug candidate ACD856, which is being developed against Alzheimer’s disease and other indications with cognitive dysfunction.

Royal Philips, a global leader in health technology, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway and improve cardiac care experiences at the Transcatheter Cardiovascular Therapeutics annual meeting.

Pharvaris presented data supporting the development program for PHA121 at the Bradykinin Symposium 2022 in Berlin.

FOXO Technologies Inc. announced the completion of its business combination with Delwinds Insurance Acquisition Corp., a publicly traded special purpose acquisition company.

Allarity Therapeutics, Inc., a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, announced that Chief Executive Officer James G. Cullem will deliver a corporate update and host investor 1x1 meetings at the Ladenburg Thalmann Healthcare Conference in New York, NY.